access to glp 1 medications GLP‑1 Equity: Strategies Bridge the Care Gap New federal agreement lowers GLP-1

Long-term outcomes in patients with type 2 diabetes receiving glimepiride combined with liraglutide or rosiglitazone

Alcohol is a depressant that can exacerbate depressive symptoms and destabilize mood, which can negate the stabilizing effects of Lamictal on bipolar disorder

And planning

By Friday, the Food and Drug Administration said it would take decisive steps to restrict compounded GLP-1s from being mass marketed as similar to FDA-approved drugs, naming Hims specifically

The higher discontinuation rate among patients with obesity raises questions about whether weight loss or adverse effects drive this trend

We look at claims